Literature DB >> 14568969

Transcriptional regulation of type I diabetes by NF-kappa B.

Salah-Eddine Lamhamedi-Cherradi1, Shijun Zheng, Brendan A Hilliard, Lingyun Xu, Jing Sun, Saaib Alsheadat, Hsiou-Chi Liou, Youhai H Chen.   

Abstract

Development of type I diabetes requires coordinated expression of myriad genes responsible for the initiation and progression of the disease. Expression of these genes are regulated by a small number of transcription factors including the Rel/NF-kappaB family. To determine the roles of the Rel/NF-kappaB family in type I diabetes, we studied multiple low-dose streptozotocin-induced diabetes in mice deficient in either c-Rel or NF-kappaB1. We found that mice deficient in each of these NF-kappaB subunits were resistant to streptozotocin-induced diabetes. However, the mechanisms of the disease resistance may differ in different cases. Deficiency in c-Rel selectively reduced Th1, but not Th2 responses, whereas NF-kappaB1 deficiency had little effect on T cell responses to anti-CD3 stimulation. Death of dendritic cells was accelerated in the absence of NF-kappaB1, whereas death of macrophages and granulocytes was affected primarily by c-Rel deficiency. Furthermore, Stat-1 expression was significantly reduced in macrophages deficient in NF-kappaB1, but not c-Rel. These results indicate that both c-Rel and NF-kappaB1are essential for the development of type I diabetes and that strategies targeting each of these subunits would be effective in preventing the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14568969     DOI: 10.4049/jimmunol.171.9.4886

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

2.  Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Christopher D Dupont; Elia D Tait; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2010-11       Impact factor: 4.823

Review 3.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

4.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

Authors:  R Eldor; A Yeffet; K Baum; V Doviner; D Amar; Y Ben-Neriah; G Christofori; A Peled; J C Carel; C Boitard; T Klein; P Serup; D L Eizirik; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-21       Impact factor: 11.205

5.  18β-glycyrrhetinic acid inhibits periodontitis via glucocorticoid-independent nuclear factor-κB inactivation in interleukin-10-deficient mice.

Authors:  H Sasaki; N Suzuki; E Alshwaimi; Y Xu; R Battaglino; L Morse; P Stashenko
Journal:  J Periodontal Res       Date:  2010-12       Impact factor: 4.419

6.  Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.

Authors:  Sreedevi Chinthamani; Olutayo Odusanwo; Nandini Mondal; Joel Nelson; Sriram Neelamegham; Olga J Baker
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

7.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

8.  Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells.

Authors:  Chunli Shao; Michael C Lawrence; Melanie H Cobb
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

9.  The tumour-suppressor p53 is not required for pancreatic beta cell death during diabetes and upon irradiation.

Authors:  Shin Yuen Nam; Ming Kei Lee; Kanaga Sabapathy
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 10.  Nuclear factor-kappaB: its role in health and disease.

Authors:  Ashok Kumar; Yasunari Takada; Aladin M Boriek; Bharat B Aggarwal
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.